Akebia Therapeutics Inc. (AKBA)

전일 마감가:

$1.30

열려 있는:

$1.34

하루 거래량:

3.11M

시가총액:

$287.15M

수익:

$194.75M

순이익/손실:

$-51.26M

주가수익비율:

-2.6346

EPS:

-0.52

순현금흐름:

$-23.38M

1주 성능:

+2.24%

1개월 성능:

-8.05%

6개월 성능:

+44.99%

1년 성능:

+55.70%

1일 변동 폭

$1.32

$1.42

52주 변동 폭

$0.7801

$2.48

Akebia Therapeutics Inc. Stock (AKBA) Company Profile

명칭

Akebia Therapeutics Inc.

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

617-871-2098

주소

245 First Street, Suite 1100, Cambridge, MA

직원

113

트위터

@akebiatx

다음 수익 날짜

2024-05-09

최신 SEC 제출 서류

AKBA's Discussions on Twitter

Akebia Therapeutics Inc. Stock (AKBA) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2022-03-31	다운그레이드	H.C. Wainwright	Buy → Neutral
2022-03-31	다운그레이드	Mizuho	Buy → Neutral
2022-03-31	다운그레이드	Needham	Buy → Hold
2022-03-31	다운그레이드	Piper Sandler	Overweight → Neutral
2021-03-08	개시	Cantor Fitzgerald	Overweight
2021-01-29	다운그레이드	JP Morgan	Neutral → Underweight
2019-11-14	재확인	Needham	Buy
2019-08-06	재확인	H.C. Wainwright	Buy
2019-07-11	재확인	H.C. Wainwright	Buy
2019-05-02	개시	JP Morgan	Overweight
2019-03-20	개시	Citigroup	Neutral
2018-09-07	재개	Morgan Stanley	Equal-Weight
2018-08-10	재확인	Needham	Buy
2018-06-06	재확인	H.C. Wainwright	Buy
2017-12-19	개시	Piper Jaffray	Overweight
2017-12-07	개시	BTIG Research	Buy
2017-09-15	개시	RBC Capital Mkts	Sector Perform
2017-07-10	재확인	H.C. Wainwright	Buy
2017-04-27	재확인	H.C. Wainwright	Buy
2017-04-27	재확인	Needham	Buy
2016-12-27	재확인	H.C. Wainwright	Buy
2016-12-20	재확인	JMP Securities	Mkt Outperform
2016-11-15	개시	Aegis Capital	Buy
2016-09-29	개시	Brean Capital	Buy
2016-03-16	재확인	Needham	Buy
2016-01-21	개시	Credit Suisse	Neutral

모두보기

Akebia Therapeutics Inc. 주식(AKBA)의 최신 뉴스

Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Benzinga

Akebia (AKBA) Up as Vafseo Gets FDA Nod for Anemia Due to CKD

Zacks Investment Research

Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday

Benzinga

Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Akebia Therapeutics (AKBA) Reports Break-Even Earnings for Q4

Zacks Investment Research

Rigel Pharmaceuticals (RIGL) Reports Break-Even Earnings for Q4

Zacks Investment Research

Akebia Therapeutics Inc. (AKBA) 재무 분석

Akebia Therapeutics Inc. (AKBA) 매출 2024

Akebia Therapeutics Inc. (AKBA) 순이익 2024

Akebia Therapeutics Inc. (AKBA) 현금흐름 2024

Akebia Therapeutics Inc. (AKBA) 주당 순이익 2024